Chronic lung diseases such as COPD (Chronic Obstructive Pulmonary Disease) and Idiopathic Pulmonary Fibrosis (IPF) have a profound impact on patients, but are difficult to treat. Patient care focuses primarily on managing symptoms. University of Groningen (UG) researchers Luke van der Koog and Erik Frijlink (FSE) want to change that: through their company, MimeCure, they are developing a revolutionary treatment method. The initial results are promising.